🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523530-30-00
Completed Phase I

Single-centre clinical trial investigating the safety and tolerability of increasing multiple doses of nebulised SS0331 in healthy participants

2025-523530-30-00 · tracked via the Priya Life Science EU tracker
Sponsor
Softox Defense Solutions AS
Sponsor type
Pharmaceutical company
Therapeutic area
Bacterial Infections and Mycoses
Decision date
20/02/2026
Enrollment target
48
Sites
Ireland

Condition studied

Treatment and post exposure prevention of respiratory tract infection, Biologic countermeasure

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523530-30-00 on CTIS ↗ ← All trials in the EU